SciSparc (SPRC) Other Non-Current Liabilities (2019 - 2025)
SciSparc (SPRC) posted Other Non-Current Liabilities of $5.2 million for Q4 2025, little changed sequentially from $5.2 million in Q2 2025, and little changed YoY from $5.2 million in Q4 2024.
SciSparc (SPRC) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
SciSparc has reported Other Non-Current Liabilities for 7 years, with the latest figure at $5.2 million in Q4 2025.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $5.2 million, changed 0.0% from the prior year.
- Other Non-Current Liabilities was little changed at $5.2 million in Q4 2025 per SPRC's latest filing, from $5.2 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $10.3 million in Q2 2022 and troughed at $497000.0 in Q3 2022.
- A 5-year average of $5.3 million and a median of $5.2 million in 2021 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2023: Other Non-Current Liabilities surged 946.15% in 2021, then sank 49.38% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $5.2 million in 2021, then changed by 0.0% to $5.2 million in 2022, then changed by 0.0% to $5.2 million in 2023, then changed by 0.0% to $5.2 million in 2024, then changed by 0.0% to $5.2 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $5.2 million, $5.2 million, and $5.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SciSparc | 830,176.72 | 830,176.72 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.19 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Dec 31, 2024 | 5.19 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Dec 31, 2022 | 5.19 Mn |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 10.25 Mn |
| Dec 31, 2021 | 5.19 Mn |
| Jun 30, 2021 | 6.26 Mn |
| Dec 31, 2020 | 2.21 Mn |
| Jun 30, 2020 | 598,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Jun 30, 2019 | 486,000.00 |